- Home
- LBTYK vs PTCT Comparison
LBTYK vs PTCT Comparison
Compare LBTYK & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LBTYK
- PTCT
- Stock Information
- Founded
- LBTYK 2004
- PTCT 1998
- Country
- LBTYK Bermuda
- PTCT United States
- Employees
- LBTYK N/A
- PTCT N/A
- Industry
- LBTYK Cable & Other Pay Television Services
- PTCT Biotechnology: Pharmaceutical Preparations
- Sector
- LBTYK Telecommunications
- PTCT Health Care
- Exchange
- LBTYK Nasdaq
- PTCT Nasdaq
- Market Cap
- LBTYK 4.1B
- PTCT 5.3B
- IPO Year
- LBTYK N/A
- PTCT 2013
- Fundamental
- Price
- LBTYK $10.88
- PTCT $71.58
- Analyst Decision
- LBTYK
- PTCT Buy
- Analyst Count
- LBTYK 0
- PTCT 17
- Target Price
- LBTYK N/A
- PTCT $73.24
- AVG Volume (30 Days)
- LBTYK 1.0M
- PTCT 1.0M
- Earning Date
- LBTYK 01-01-0001
- PTCT 11-04-2025
- Dividend Yield
- LBTYK N/A
- PTCT N/A
- EPS Growth
- LBTYK N/A
- PTCT N/A
- EPS
- LBTYK N/A
- PTCT 8.94
- Revenue
- LBTYK $4,770,600,000.00
- PTCT $1,779,150,000.00
- Revenue This Year
- LBTYK $13.25
- PTCT $119.02
- Revenue Next Year
- LBTYK $1.75
- PTCT N/A
- P/E Ratio
- LBTYK N/A
- PTCT $8.03
- Revenue Growth
- LBTYK 170.50
- PTCT 97.54
- 52 Week Low
- LBTYK $9.21
- PTCT $35.95
- 52 Week High
- LBTYK $14.83
- PTCT $73.98
- Technical
- Relative Strength Index (RSI)
- LBTYK 42.75
- PTCT 71.08
- Support Level
- LBTYK $10.74
- PTCT $66.10
- Resistance Level
- LBTYK $11.14
- PTCT $73.98
- Average True Range (ATR)
- LBTYK 0.37
- PTCT 2.58
- MACD
- LBTYK -0.01
- PTCT 0.10
- Stochastic Oscillator
- LBTYK 32.02
- PTCT 70.62
About LBTYK Liberty Global Ltd. Class C
Liberty Global is a holding company with interests in European telecom companies in the UK, the Netherlands, Belgium, Ireland, and Slovakia. Liberty owns the main cable network in each of these geographies and has pursued a strategy since 2016 to merge or partner with mobile network operators to be able to offer converged services. Liberty also owns minority stakes in other media, entertainment, and cloud companies.
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.